What is Pediatrix Medical Group's EV / EBITDA?

Pediatrix Medical Group (MD) reported EV / EBITDA of 9.1× in Q1 2026.

What is the long-term trend for Pediatrix Medical Group's EV / EBITDA?

Over 4 years (2020 to 2025), Pediatrix Medical Group's EV / EBITDA has grown at a 3.0% compound annual growth rate (CAGR), from 8.1× to 9.1×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Pediatrix Medical Group (MD) EV / EBITDA

Screener

EV / EBITDA at other companies

ARD

Ardent Health PartnersARDT

3.6×-0.9×

InfuSystem HoldingsINFU

8×+1.1×

Utah Medical ProductsUTMD

8×—

Nutex Health Inc.NUTX

3.4×0.0×

GE HealthCare TechnologiesGEHC

11.9×-1.3×

Tenet HealthcareTHC

5×-0.9×

Other financials

Income statement

See full

Revenue$476.2M+3.9%

Operating income$41.7M+29.8%

Net income$29.6M+42.6%

EPS (diluted)$0.36+50.0%

Balance sheet

See full

Cash & equivalents$205.8M+108%

Total debt$629.7M-3.9%

Total equity$878.6M+11.3%

Total assets$2.1B+3.9%

Cash flow

See full

Operating cash flow-$129.8M-10.5%

CapEx$6.2M+88.3%

Free cash flow-$136.1M-12.7%

Valuation

See full

Market cap$2.15B+71.3%

Enterprise value$2.58B+53.2%

P/E12.4×—

P/S1.1×+0.5×

Profitability

See full

Operating margin11.3%—

Net margin9%—

FCF margin12.3%+2.5pp

Returns & leverage

See full

Return on equity20.9%—

Debt / equity0.7×-0.1×

Current ratio1.3×-0.5×

Where this comes from

Calculated from Pediatrix Medical Group’s reported figures.

enterprise value/ebitda=9.1×

Based on the most recent quarter.

The source filing: Pediatrix Medical Group’s 10-Q, filed May 5, 2026. Open the filing →

Filed: May 5, 2026, 7:00 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001193125-26-204993

FAQ

What is Pediatrix Medical Group's EV / EBITDA?: Pediatrix Medical Group (MD) reported EV / EBITDA of 9.1× in Q1 2026.
What is the long-term trend for Pediatrix Medical Group's EV / EBITDA?: Over 4 years (2020 to 2025), Pediatrix Medical Group's EV / EBITDA has grown at a 3.0% compound annual growth rate (CAGR), from 8.1× to 9.1×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Pediatrix Medical Group's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Pediatrix Medical Group MD EV / EBITDA

EV / EBITDA at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Pediatrix Medical Group's ev / ebitda.